A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)

计划入组 673 人 · 首次发布于 2022 年 12 月 5 日

A Study to Evaluate the Efficacy and Safety of AD-233A, AD-233B, AD-233C and/or AD-233D Combination Therapy

计划入组 354 人 · 首次发布于 2026 年 9 月 11 日

Evaluating the Pharmacokinetic Interaction Between AD-2101 and AD-2102

计划入组 25 人 · 首次发布于 2020 年 10 月 23 日

Vitamin AD

AD-224

AD-223

AD SCIENTIAM

France

Annovis Bio

United States

GALENIKA, PREDSTAVITELSTVO

Russia

Cognito Therapeutics' Spectris AD Demonstrates Significant Delay in Alzheimer's Disease Progression Through Non-Invasive Neuromodulation

Phase 3 HOPE Trial Tests Novel Light-Sound Therapy Device for Moderate Alzheimer's Treatment

Cognito Therapeutics' Spectris Device Shows Promise in Modulating Brain Resilience Pathways in Alzheimer's Disease